ArticleCancer management and research2026

Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer.

Emmanuel Asante-Asamani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.